181 related articles for article (PubMed ID: 37813544)
1. Identification of molecular subphenotypes in two cohorts of paediatric ARDS.
Yehya N; Zinter MS; Thompson JM; Lim MJ; Hanudel MR; Alkhouli MF; Wong H; Alder MN; McKeone DJ; Halstead ES; Sinha P; Sapru A
Thorax; 2024 Jan; 79(2):128-134. PubMed ID: 37813544
[TBL] [Abstract][Full Text] [Related]
2. Validation and utility of ARDS subphenotypes identified by machine-learning models using clinical data: an observational, multicohort, retrospective analysis.
Maddali MV; Churpek M; Pham T; Rezoagli E; Zhuo H; Zhao W; He J; Delucchi KL; Wang C; Wickersham N; McNeil JB; Jauregui A; Ke S; Vessel K; Gomez A; Hendrickson CM; Kangelaris KN; Sarma A; Leligdowicz A; Liu KD; Matthay MA; Ware LB; Laffey JG; Bellani G; Calfee CS; Sinha P;
Lancet Respir Med; 2022 Apr; 10(4):367-377. PubMed ID: 35026177
[TBL] [Abstract][Full Text] [Related]
3. Identifying molecular phenotypes in sepsis: an analysis of two prospective observational cohorts and secondary analysis of two randomised controlled trials.
Sinha P; Kerchberger VE; Willmore A; Chambers J; Zhuo H; Abbott J; Jones C; Wickersham N; Wu N; Neyton L; Langelier CR; Mick E; He J; Jauregui A; Churpek MM; Gomez AD; Hendrickson CM; Kangelaris KN; Sarma A; Leligdowicz A; Delucchi KL; Liu KD; Russell JA; Matthay MA; Walley KR; Ware LB; Calfee CS
Lancet Respir Med; 2023 Nov; 11(11):965-974. PubMed ID: 37633303
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory subphenotypes previously identified in ARDS are associated with mortality at intensive care unit discharge: a secondary analysis of a prospective observational study.
Slim MA; van Amstel RBE; Bos LDJ; Cremer OL; ; Wiersinga WJ; van der Poll T; van Vught LA
Crit Care; 2024 May; 28(1):151. PubMed ID: 38715131
[TBL] [Abstract][Full Text] [Related]
5. Latent class analysis-derived subphenotypes are generalisable to observational cohorts of acute respiratory distress syndrome: a prospective study.
Sinha P; Delucchi KL; Chen Y; Zhuo H; Abbott J; Wang C; Wickersham N; McNeil JB; Jauregui A; Ke S; Vessel K; Gomez A; Hendrickson CM; Kangelaris KN; Sarma A; Leligdowicz A; Liu KD; Matthay MA; Ware LB; Calfee CS
Thorax; 2022 Jan; 77(1):13-21. PubMed ID: 34253679
[TBL] [Abstract][Full Text] [Related]
6. Alveolar Biomarker Profiles in Subphenotypes of the Acute Respiratory Distress Syndrome.
Sathe NA; Morrell ED; Bhatraju PK; Fessler MB; Stapleton RD; Wurfel MM; Mikacenic C
Crit Care Med; 2023 Jan; 51(1):e13-e18. PubMed ID: 36519995
[TBL] [Abstract][Full Text] [Related]
7. Latent Class Analysis Reveals COVID-19-related Acute Respiratory Distress Syndrome Subgroups with Differential Responses to Corticosteroids.
Sinha P; Furfaro D; Cummings MJ; Abrams D; Delucchi K; Maddali MV; He J; Thompson A; Murn M; Fountain J; Rosen A; Robbins-Juarez SY; Adan MA; Satish T; Madhavan M; Gupta A; Lyashchenko AK; Agerstrand C; Yip NH; Burkart KM; Beitler JR; Baldwin MR; Calfee CS; Brodie D; O'Donnell MR
Am J Respir Crit Care Med; 2021 Dec; 204(11):1274-1285. PubMed ID: 34543591
[No Abstract] [Full Text] [Related]
8. Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials.
Calfee CS; Delucchi K; Parsons PE; Thompson BT; Ware LB; Matthay MA;
Lancet Respir Med; 2014 Aug; 2(8):611-20. PubMed ID: 24853585
[TBL] [Abstract][Full Text] [Related]
9. Host-Response Subphenotypes Offer Prognostic Enrichment in Patients With or at Risk for Acute Respiratory Distress Syndrome.
Kitsios GD; Yang L; Manatakis DV; Nouraie M; Evankovich J; Bain W; Dunlap DG; Shah F; Barbash IJ; Rapport SF; Zhang Y; DeSensi RS; Weathington NM; Chen BB; Ray P; Mallampalli RK; Benos PV; Lee JS; Morris A; McVerry BJ
Crit Care Med; 2019 Dec; 47(12):1724-1734. PubMed ID: 31634231
[TBL] [Abstract][Full Text] [Related]
10. Latent class analysis of ARDS subphenotypes: a secondary analysis of the statins for acutely injured lungs from sepsis (SAILS) study.
Sinha P; Delucchi KL; Thompson BT; McAuley DF; Matthay MA; Calfee CS;
Intensive Care Med; 2018 Nov; 44(11):1859-1869. PubMed ID: 30291376
[TBL] [Abstract][Full Text] [Related]
11. Subphenotypes in patients with acute respiratory distress syndrome treated with high-flow oxygen.
Blot PL; Chousterman BG; Santafè M; Cartailler J; Pacheco A; Magret M; Masclans JR; Artigas A; Roca O; García-de-Acilu M
Crit Care; 2023 Nov; 27(1):419. PubMed ID: 37915062
[TBL] [Abstract][Full Text] [Related]
12. Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial.
Calfee CS; Delucchi KL; Sinha P; Matthay MA; Hackett J; Shankar-Hari M; McDowell C; Laffey JG; O'Kane CM; McAuley DF;
Lancet Respir Med; 2018 Sep; 6(9):691-698. PubMed ID: 30078618
[TBL] [Abstract][Full Text] [Related]
13. Identification of phenotypes in paediatric patients with acute respiratory distress syndrome: a latent class analysis.
Dahmer MK; Yang G; Zhang M; Quasney MW; Sapru A; Weeks HM; Sinha P; Curley MAQ; Delucchi KL; Calfee CS; Flori H; ;
Lancet Respir Med; 2022 Mar; 10(3):289-297. PubMed ID: 34883088
[TBL] [Abstract][Full Text] [Related]
14. Biological Subphenotypes of Acute Respiratory Distress Syndrome Show Prognostic Enrichment in Mechanically Ventilated Patients without Acute Respiratory Distress Syndrome.
Heijnen NFL; Hagens LA; Smit MR; Cremer OL; Ong DSY; van der Poll T; van Vught LA; Scicluna BP; Schnabel RM; van der Horst ICC; Schultz MJ; Bergmans DCJJ; Bos LDJ
Am J Respir Crit Care Med; 2021 Jun; 203(12):1503-1511. PubMed ID: 33465019
[No Abstract] [Full Text] [Related]
15. Causes and attributable fraction of death from ARDS in inflammatory phenotypes of sepsis.
Evrard B; Sinha P; Delucchi K; Hendrickson CM; Kangelaris KN; Liu KD; Willmore A; Wu N; Neyton L; Schmiege E; Gomez A; Kerchberger VE; Zalucky A; Matthay MA; Ware LB; Calfee CS
Crit Care; 2024 May; 28(1):164. PubMed ID: 38745253
[TBL] [Abstract][Full Text] [Related]
16. Elevated Plasma Interleukin-18 Identifies High-Risk Acute Respiratory Distress Syndrome Patients not Distinguished by Prior Latent Class Analyses Using Traditional Inflammatory Cytokines: A Retrospective Analysis of Two Randomized Clinical Trials.
Moore AR; Pienkos SM; Sinha P; Guan J; O'Kane CM; Levitt JE; Wilson JG; Shankar-Hari M; Matthay MA; Calfee CS; Baron RM; McAuley DF; Rogers AJ
Crit Care Med; 2023 Dec; 51(12):e269-e274. PubMed ID: 37695136
[TBL] [Abstract][Full Text] [Related]
17. Six-month and 12-month patient outcomes based on inflammatory subphenotypes in sepsis-associated ARDS: secondary analysis of SAILS-ALTOS trial.
Hashem MD; Hopkins RO; Colantuoni E; Dinglas VD; Sinha P; Aronson Friedman L; Morris PE; Jackson JC; Hough CL; Calfee CS; Needham DM
Thorax; 2022 Jan; 77(1):22-30. PubMed ID: 34112703
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of parsimonious algorithms to classify acute respiratory distress syndrome phenotypes: a secondary analysis of randomised controlled trials.
Sinha P; Delucchi KL; McAuley DF; O'Kane CM; Matthay MA; Calfee CS
Lancet Respir Med; 2020 Mar; 8(3):247-257. PubMed ID: 31948926
[TBL] [Abstract][Full Text] [Related]
19. Rapidly improving ARDS differs clinically and biologically from persistent ARDS.
Valda Toro PL; Willmore A; Wu NE; Delucchi KL; Jauregui A; Sinha P; Liu KD; Hendrickson CM; Sarma A; Neyton LPA; Leligdowicz A; Langelier CR; Zhuo H; Jones C; Kangelaris KN; Gomez AD; Matthay MA; Calfee CS
Crit Care; 2024 Apr; 28(1):132. PubMed ID: 38649920
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal respiratory subphenotypes in patients with COVID-19-related acute respiratory distress syndrome: results from three observational cohorts.
Bos LDJ; Sjoding M; Sinha P; Bhavani SV; Lyons PG; Bewley AF; Botta M; Tsonas AM; Serpa Neto A; Schultz MJ; Dickson RP; Paulus F;
Lancet Respir Med; 2021 Dec; 9(12):1377-1386. PubMed ID: 34653374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
